Neuberger High Yield Strategies Fund Launches New Rights Offering for Shareholders

Neuberger High Yield Strategies Fund Launches New Rights Offering

Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) recently made headlines with the announcement of a new rights offering designed to expand its equity base and offer additional investment opportunities to shareholders. The Fund has successfully secured approval for the issuance of transferable rights to its common stockholders, allowing them to acquire more shares at a price lower than the current market value.

Background of the Offering

As of the record date, March 23, 2026, shareholders of the Fund will be granted one right for each share they hold. The rights will enable holders to purchase one additional share of common stock for every three rights they own (1-for-3). For those who own fewer than three shares, they can still purchase one additional share. This initiative is particularly notable as it marks a concerted effort by the Fund to increase assets available for investment, aligning with its objective of achieving a high total return through both income generation and capital appreciation.

Key Terms and Conditions

The offering is set to expire on April 15, 2026, with the subscription price determined by the average closing price of the stock over several days leading up to the expiration. If this average is below 92.5% of the Fund's net asset value (NAV), the subscription price will adjust accordingly. Additionally, the offering anticipates a positive impact on the overall expense ratio by distributing fixed costs over an increased asset base, enhancing potential liquidity and trading volume for NHS common stock.

Moreover, the Fund has assured investors that it expects to maintain its current monthly distribution level during and after the rights offering. A regular distribution is slated for March 31, 2026, and another for April 30, 2026—however, these will not apply to those acquired under the rights offering, as those shares will be issued post-record date.

Benefits of the Rights Offering

The rights offering presents an attractive opportunity for both the Fund and its existing shareholders. Some of the key benefits include:

1. Access to New Capital: The proceeds from the rights offering will allow the Fund to capitalize on promising investment opportunities, thereby potentially augmenting its long-term returns.
2. Discounted Purchase Price: Shareholders are presented with the opportunity to purchase additional shares at a discount, a strategic move that aims to enhance their investment value over time.
3. Increased Liquidity: The introduction of new shares is likely to elevate trading volumes and liquidity for NHS common stock, benefiting both current and prospective investors.

The Rights will be transferable and traded under the symbol ‘NHS RT’ on the NYSE American. This provides shareholders with flexibility, as they may choose to sell their rights during the offering period.

Conclusion

The Neuberger High Yield Strategies Fund is confident that this rights offering is a significant step towards empowering its shareholders and fostering growth within the fund. As the investment landscape evolves, the Fund's proactive approach to increasing its asset base stands out as a forward-thinking strategy designed to maximize returns for its investors. Shareholders looking for additional insights or wishing to participate in the offering are encouraged to keep an eye out for further updates and the official prospectus, which will provide detailed instructions for exercising or trading their rights. For more specific inquiries, investors can contact the Fund’s information agent.

In summary, Neuberger High Yield Strategies Fund’s new rights offering not only allows for greater investment potential but also reinforces its commitment to the financial well-being of its shareholders, paving the way for further growth and opportunities in the market.